Гематология
1428 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (86)
- Thrombosis Research · Elsevier (81)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- British Journal of Haematology · Wiley (78)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (73)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (68)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (64)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Transfusion · Wiley (53)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (8)
- Leukemia · Springer Nature (8)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Maternal iron status in pregnancy: The liver as an understudied confounder
- Response to the Letter to the Editor regarding ‘Evaluating high‐sensitivity troponin levels in patients with sickle cell disease presenting to the emergency department’
- Troponin elevation and myocardial infarction in patients with haematological disorders
- Genomic staging in myeloma: The need for population‐specific validation
- Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma
- Outcomes of refractory and early‐relapsed large B‐cell lymphoma patients after first‐line treatment in the prospective Real‐world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre‐CAR T era
- NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis
- Flow cytometric identification of plasmacytoid dendritic cells in acute myeloid leukaemia: Challenges and practical considerations
- A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
- Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy
- Temporal trends and demographic patterns in depression prevalence among adults with sickle cell disease
- Real‐world evidence on the safety and effectiveness of thrombopoietin receptor agonists in aplastic anaemia: A descriptive study using Japanese hospital administrative data
- Sirolimus is effective for paediatric Evans syndrome and secondary autoimmune cytopenias: A retrospective cohort study
- Treatment‐free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations
- Comparison of post‐transplant cyclophosphamide and low‐dose anti‐thymocyte globulin with dose‐dependent effects in mismatched unrelated donor transplantation
- Real‐world romiplostim dosing, response and home administration in paediatric immune thrombocytopenia
- The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes
- Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial
- Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study
- Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma
- Characteristics and outcome of T‐cell/histiocyte‐rich large B‐cell lymphoma in childhood and adolescence: An international retrospective analysis
- Deep molecular remission and encouraging survival without transplantation: V‐CAG for arsenic‐resistant relapsed APL
- Efficacy of a virtual reality headset in the management of severe pain during a vaso‐occlusive crisis: A single‐centre study in adults with sickle cell disease
- Generalised FDG‐avid lymphadenopathy in Kikuchi‐Fujimoto disease mimicking malignant lymphoma
- Nodular amyloid light chain amyloidosis of the tongue
- Unusual combination of Snapper‐Schneid bodies and lenalidomide‐induced Fanconi syndrome
- A case of chronic myeloid leukaemia complicated by SF3B1‐mutant myelodysplastic syndrome
- In a nutshell: Haematological immune‐related adverse events
- Maternal iron homeostasis, disorders and pregnancy outcomes
- Correction to ‘Efficiency and safety gains from bedside electronic transfusion checks in four hospitals in England’